isabelobrien, Author at European Medical Journal - Page 11 of 68

Illustration of scientific tools

Novartis to tackle rare disease diagnosis with AI

Novartis is partnering with Atropos Health to develop AI models that accelerate rare disease diagnosis, starting with a rare blood disorder.

Preventing Diabetes Complications

Catherine Glass sits down with leading diabetes researcher Vinod Patel to discuss the future of Type 2 diabetes care, exploring new technologies, predictive tools, retinal imaging, and much more.

Phone-with-heart-monitor

HonorHealth hires longevity expert Nicholas Schork

HonorHealth appoints Dr Nicholas Schork to lead AI-driven disease interception research, reflecting an industry shift towards prevention.

5 minutes with Dr Henar Hevia, J&J Innovative Medicine

Henar Hevia, Senior Director, EMEA Therapeutic Area Lead, Oncology, reveals what it’s like to work in oncology today, especially at J&J.

AstraZeneca and Viseven win 2025 HBA ACE Awards

AstraZeneca and Viseven win the 2025 HBA ACE Awards for innovative workforce and community programmes shaping the future of healthcare.

Two US flags

AbbVie invests $195m in US expansion ahead of tariffs

AbbVie to invest $195m in manufacturing expansion as pharma rushes to boost domestic capacity ahead of expected drug import tariffs.

Two hands moving towards each other as if they are going to shake hands

Bayer deal caps big week for pancreatic cancer research

Bayer announces deal with Kumquat for a pancreatic cancer KRAS inhibitor, plus, promising mRNA vaccine research emerges from Phase 1 trial.

Ireland urged to seize €97bn FemTech opportunity

Ireland could become a global leader in FemTech innovation, but only if it acts now, claims a new report by Health Innovation Hub Ireland.

New evidence links beta-HPV to skin cancer

A patient case study has uncovered a potential link between beta-HPV and the common skin cancer, cutaneous squamous cell carcinoma (cSCC).

BMS’ Emma Charles on access, impact and inclusion

Emma shares her vision for healthcare, how AI is reshaping pharma and why access to innovation must be faster and fairer in Europe.